技术指标
指标
数值
方向
MACD(12,26,9)
-0.040
卖出
RSI(14)
25.136
卖出
STOCH(KDJ)(9,3,3)
14.929
超卖
ATR(14)
0.103
低波动
CCI(14)
-107.674
卖出
Williams %R
88.479
超卖
TRIX(12,20)
-1.616
卖出
StochRSI(14)
0.000
超卖
搜索
BioNexus Gene Lab Corp
BGLC添加自选
1.280USD
-0.040-3.03%
收盘 07-31 16:00（美东）报价延迟15分钟
3.09M总市值
亏损市盈率 TTM
关键数据
--今开
1.370最高
10.01K成交量
亏损市盈率 TTM
--市盈率动
--股息TTM
0.41%换手率
1.320昨收
1.270最低
10.76K成交额
亏损市盈率静
0.38市净率
0.00%股息率 TTM
-31.37%ROA
15.60052周最高
0.43量比
-1.60M净利润
2.42M总股本
-1.4855每股收益TTM
2.20Beta
-36.62%ROE
1.92052周最低
7.58%振幅
-3.46%毛利率
3.09M总市值
-7.79回报/风险
4.49%风险率
TradingKey BioNexus Gene Lab Corp股票评分
单位: USD 更新时间: 2026-07-31操作建议
BioNexus Gene Lab Corp当前公司基本面数据相对非常健康，增长潜力较大。当前估值合理，在生物技术与医疗研究行业排名190/385位。机构持股占比非常高，中期看，股价处于下降通道。近一个月，市场表现非常差，但基本面评分较高。目前股价在压力位和支撑位之间，可以做区间波段操作。
BioNexus Gene Lab Corp评分
压力支撑
由于公司未披露，未能获取相关数据
多维评测
本期评分
上期评分
公司舆情
过去24小时
热度
过冷
过热
看好
BioNexus Gene Lab Corp亮点
亮点风险
BioNexus Gene Lab Corp. is a biotechnology company specializing in precision diagnostics and specialty chemical solutions. The Company, through its wholly owned subsidiary Chemrex Corporation Sdn. Bhd., focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. Its segments include Trading of industrial chemicals, Provision for genomic screening services, and Investment holding. The Provision for genomic screening services segment includes commercializing proprietary blood-based diagnostic test for early disease detection. Its subsidiary MRNA Scientific Sdn. Bhd owns algorithm software, technology, and know-how related to the detection of common diseases through blood analysis which it uses in its business.
业绩增长期
公司处于发展阶段，最新年度总收入7.42M美元
估值高估
公司最新PE估值-0.89，处于3年历史高位
机构加仓
最新机构持股50.43K股，环比增加16.55%
分析师目标
根据
0
位分析师
--
评级
--
目标均价
--
涨幅空间
BioNexus Gene Lab Corp新闻
即将为您带来更多新闻，敬请期待。。。
技术指标
移动平均线
指标
数值
方向
MA5
1.344
卖出
MA10
1.461
卖出
MA20
1.623
卖出
MA50
1.976
卖出
MA100
2.099
卖出
MA200
2.971
卖出
财务指标
每股收益
由于公司未披露，未能获取相关数据
营业总收入
由于公司未披露，未能获取相关数据
BioNexus Gene Lab Corp简介
BioNexus Gene Lab Corp. is a biotechnology company specializing in precision diagnostics and specialty chemical solutions. The Company, through its wholly owned subsidiary Chemrex Corporation Sdn. Bhd., focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. Its segments include Trading of industrial chemicals, Provision for genomic screening services, and Investment holding. The Provision for genomic screening services segment includes commercializing proprietary blood-based diagnostic test for early disease detection. Its subsidiary MRNA Scientific Sdn. Bhd owns algorithm software, technology, and know-how related to the detection of common diseases through blood analysis which it uses in its business.
公司代码BGLC
公司BioNexus Gene Lab Corp
CEOTan (Lee Su-Leng)
网址https://www.bionexusgenelab.com/
公司股东
相关品种
热门品种
常见问题
BioNexus Gene Lab Corp(BGLC)的当前股价是多少？
BioNexus Gene Lab Corp(BGLC)的当前股价是 1.28。
BioNexus Gene Lab Corp的股票代码是什么？
BioNexus Gene Lab Corp的股票代码是BGLC。
BioNexus Gene Lab Corp股票的52周最高点是多少？
BioNexus Gene Lab Corp股票的52周最高点是15.60。
BioNexus Gene Lab Corp股票的52周最低点是多少？
BioNexus Gene Lab Corp股票的52周最低点是1.92。
BioNexus Gene Lab Corp的市值是多少？
BioNexus Gene Lab Corp的市值是3.09M。
BioNexus Gene Lab Corp(BGLC)股票的每股收益（EPS TTM）是多少
BioNexus Gene Lab Corp(BGLC)股票的每股收益（EPS TTM）是-1.61。